Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tDCS During Contralaterally Controlled FES for Upper Extremity Hemiplegia

NCT05866003 is registered in ClinicalTrials.gov with MetroHealth Medical Center as lead sponsor.

NCT NCT05866003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tDCS During Contralaterally Controlled FES for Upper Extremity Hemiplegia
Lead sponsor
MetroHealth Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2023
Completion date
April 30, 2028
Enrollment
63 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemiplegia, stroke, upper extremity paresis